Description of Company and Basis of Presentation (Tables)

3 Months Ended

Jul. 31, 2023

Accounting Policies [Abstract]

Schedule of balance sheet

	As of July 31, 2023
Consolidated Balance Sheet	(as reported)			(adjustments)			(as restated)
ASSETS
Current assets:
Cash and cash equivalents	$	24,898		$	–		$	24,898
Accounts receivable, net		16,209			–			16,209
Contract assets		14,454			–			14,454
Inventory		40,866			–			40,866
Prepaid expenses and other current assets		1,892			–			1,892
Total current assets		98,319			–			98,319
Property and equipment, net		182,299			536			182,835
Operating lease right-of-use assets		42,374			–			42,374
Deferred tax assets		114,238			133			114,371
Other assets		4,757			–			4,757
Restricted cash		350			–			350
Total assets	$	442,337		$	669		$	443,006
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	22,813		$	–		$	22,813
Accrued compensation and benefits		4,667			–			4,667
Contract liabilities		33,019			–			33,019
Convertible senior notes, net		–			140,888			140,888
Current portion of operating lease liabilities		1,262			–			1,262
Other current liabilities		2,296			999			3,295
Total current liabilities		64,057			141,887			205,944
Convertible senior notes, net		140,888			(140,888	)		–
Operating lease liabilities, less current portion		45,370			–			45,370
Finance lease liabilities, less current portion		1,424			–			1,424
Total liabilities		251,739			999			252,738
Commitments and contingencies		–			–			–
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding at respective dates		–			–			–
Common stock, $0.001 par value; 150,000 shares authorized; 63,111 and 62,692 shares issued and outstanding at respective dates		63			–			63
Additional paid-in capital		623,445			–			623,445
Accumulated deficit		(432,910	)		(330	)		(433,240	)
Total stockholders’ equity		190,598			(330	)		190,268
Total liabilities and stockholders’ equity	$	442,337		$	669		$	443,006

Schedule of statement of loss and comprehensive loss

	Three Months Ended July 31, 2023
Consolidated Statement of Loss and Comprehensive Loss	(as reported)			(adjustments)			(as restated)
Revenues	$	37,726		$	–		$	37,726
Cost of revenues		33,626			–			33,626
Gross profit		4,100			–			4,100
Operating expenses:
Selling, general and administrative		6,263			–			6,263
Total operating expenses		6,263			–			6,263
Operating loss		(2,163	)		–			(2,163	)
Interest expense		(775	)		(50	)		(825	)
Other income, net		258			–			258
Net loss before income taxes		(2,680	)		(50	)		(2,730	)
Income tax benefit		(587	)		(21	)		(608	)
Net loss	$	(2,093	)	$	(29	)	$	(2,122	)
Comprehensive loss	$	(2,093	)	$	(29	)	$	(2,122	)
Net loss per share:
Basic	$	(0.03	)		–		$	(0.03	)
Diluted	$	(0.03	)		–		$	(0.03	)
Weighted average common shares outstanding:
Basic		62,838			–			62,838
Diluted		62,838			–			62,838

Schedule of statement of stockholder equity

	Three Months Ended July 31, 2023
	Accumulated Deficit			Total Stockholders’ Equity						Accumulated Deficit			Total Stockholders’ Equity
Condensed Consolidated Statement of Stockholders’ Equity	(as reported)			(as reported)			(adjustments)			(as restated)			(as restated)
Balances at April 30, 2023	$	(430,817	)	$	189,470		$	(301	)	$	(431,118	)	$	189,169
Common stock issued under equity compensation plans		–			878			–			–			878
Stock-based compensation expense		–			2,343			–			–			2,343
Net loss		(2,093	)		(2,093	)		(29	)		(2,122	)		(2,122	)
Balances at July 31, 2023	$	(432,910	)	$	190,598		$	(330	)	$	(433,240	)	$	190,268

Schedule of statement of cash flows

	Three Months Ended July 31 2023
Consolidated Statement of Cash Flows	(as reported)			(adjustments)			(as restated)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(2,093	)	$	(29	)	$	(2,122	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation		2,343			–			2,343
Depreciation and amortization		2,649			–			2,649
Amortization of debt issuance costs		339			–			339
Deferred income taxes		(599	)		(21	)		(620	)
Loss on disposal of property and equipment		46			–			46
Changes in operating assets and liabilities:
Accounts receivable, net		2,089			–			2,089
Contract assets		(4,845	)		–			(4,845	)
Inventory		3,042			–			3,042
Prepaid expenses and other assets		(131	)		–			(131	)
Accounts payable		4,684			–			4,684
Accrued compensation and benefits		(4,113	)		–			(4,113	)
Contract liabilities		(4,333	)		–			(4,333	)
Other accrued expenses and liabilities		644			92			736
Net cash used in operating activities		(278	)		42			(236	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment		(14,114	)		(42	)		(14,156	)
Net cash used in investing activities		(14,114	)		(42	)		(14,156	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock under equity compensation plans		878			–			878
Principal payments on finance leases		(130	)		–			(130	)
Net cash provided by financing activities		748			–			748
Net decrease in cash, cash equivalents and restricted cash		(13,644	)		–			(13,644	)
Cash, cash equivalents and restricted cash, beginning of period		38,892			–			38,892
Cash, cash equivalents and restricted cash, end of period	$	25,248			–		$	25,248
Supplemental disclosures of cash flow information:
Cash paid for interest	$	27		$	–		$	27
Cash paid for income taxes	$	12		$	–		$	12
Supplemental disclosures of non-cash activities:
Unpaid purchases of property and equipment in accounts payable	$	7,636		$	93		$	7,729